7,580 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by Apollon Wealth Management LLC

Apollon Wealth Management LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,580 shares of the company's stock, valued at approximately $256,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. NEA Management Company LLC increased its position in Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock worth $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after acquiring an additional 2,021,394 shares in the last quarter. ARK Investment Management LLC increased its position in shares of Tempus AI by 355.0% in the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock worth $134,604,000 after acquiring an additional 1,855,459 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Tempus AI by 1.0% in the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company's stock worth $45,920,000 after acquiring an additional 8,387 shares in the last quarter. Finally, Tidal Investments LLC acquired a new stake in shares of Tempus AI in the third quarter worth $7,633,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Stock Down 7.7 %

NASDAQ TEM traded down $6.85 during trading hours on Tuesday, reaching $82.59. 13,962,679 shares of the company traded hands, compared to its average volume of 13,829,895. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The company has a 50 day moving average of $47.46 and a two-hundred day moving average of $50.72.

Insider Buying and Selling at Tempus AI

In other news, major shareholder Bradley A. Keywell sold 395,800 shares of the firm's stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the transaction, the insider now directly owns 16,164,449 shares in the company, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jennifer A. Doudna sold 1,320 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $90.00, for a total transaction of $118,800.00. Following the completion of the transaction, the director now owns 36,011 shares in the company, valued at approximately $3,240,990. The trade was a 3.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,401,779 shares of company stock worth $115,707,361 in the last ninety days.

Wall Street Analysts Forecast Growth

TEM has been the subject of several recent research reports. TD Cowen reissued a "buy" rating and issued a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. William Blair lowered shares of Tempus AI from an "outperform" rating to a "market perform" rating in a report on Wednesday, February 12th. Loop Capital lowered their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday, January 14th. Needham & Company LLC reaffirmed a "buy" rating and set a $56.00 price target on shares of Tempus AI in a report on Tuesday, January 14th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and raised their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and an average price target of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.